Citigroup’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$108K Buy
13,049
+1,808
+16% +$18.7K ﹤0.01% 4252
2025
Q4
$139K Buy
11,241
+7,329
+187% +$78.5K ﹤0.01% 4165
2025
Q3
$34.5K Sell
3,912
-30,277
-89% -$235K ﹤0.01% 4607
2025
Q2
$218K Sell
34,189
-52,995
-61% -$303K ﹤0.01% 4022
2025
Q1
$424K Buy
87,184
+1,665
+2% +$13.8K ﹤0.01% 3761
2024
Q4
$818K Buy
85,519
+45,881
+116% +$421K ﹤0.01% 3514
2024
Q3
$331K Buy
39,638
+17,707
+81% +$161K ﹤0.01% 4004
2024
Q2
$150K Buy
21,931
+9,564
+77% +$41.2K ﹤0.01% 4025
2024
Q1
$31.3K Buy
12,367
+4,783
+63% +$10.8K ﹤0.01% 4877
2023
Q4
$18.2K Sell
7,584
-7,484
-50% -$17.6K ﹤0.01% 5024
2023
Q3
$51.2K Sell
15,068
-178,922
-92% -$992K ﹤0.01% 4125
2023
Q2
$1.43M Sell
193,990
-133,369
-41% -$1.24M ﹤0.01% 2532
2023
Q1
$3.39M Buy
327,359
+118,396
+57% +$1.43M ﹤0.01% 1702
2022
Q4
$2.47M Sell
208,963
-25,358
-11% -$392K ﹤0.01% 1883
2022
Q3
$4.92M Buy
234,321
+84,699
+57% +$2.36M 0.01% 1577
2022
Q2
$4.64M Buy
149,622
+84,482
+130% +$2.88M 0.01% 1583
2022
Q1
$2.67M Sell
65,140
-71,189
-52% -$3.14M ﹤0.01% 2120
2021
Q4
$5.93M Buy
136,329
+95,772
+236% +$4.33M 0.01% 1700
2021
Q3
$2.03M Sell
40,557
-61,001
-60% -$3.69M ﹤0.01% 2538
2021
Q2
$6.4M Buy
101,558
+46,904
+86% +$3.01M 0.01% 1713
2021
Q1
$5.08M Buy
54,654
+26,084
+91% +$2.67M ﹤0.01% 1778
2020
Q4
$2.56M Buy
28,570
+11,811
+70% +$1.08M ﹤0.01% 2622
2020
Q3
$1.73M Sell
16,759
-95,537
-85% -$10.3M ﹤0.01% 2775
2020
Q2
$8.88M Buy
112,296
+79,054
+238% +$5.89M 0.01% 1392
2020
Q1
$1.92M Sell
33,242
-236
-0.7% -$13.6K ﹤0.01% 2517
2019
Q4
$1.81M Sell
33,478
-24,223
-42% -$1.31M ﹤0.01% 3105
2019
Q3
$3.02M Buy
57,701
+13,036
+29% +$607K ﹤0.01% 2413
2019
Q2
$2.16M Buy
44,665
+15,307
+52% +$734K ﹤0.01% 2769
2019
Q1
$1.48M Sell
29,358
-31,479
-52% -$1.86M ﹤0.01% 2983
2018
Q4
$3.61M Buy
60,837
+33,424
+122% +$2.15M 0.01% 2127
2018
Q3
$1.8M Buy
27,413
+19,894
+265% +$1.16M ﹤0.01% 2849
2018
Q2
$380K Sell
7,519
-31,377
-81% -$1.63M ﹤0.01% 4391
2018
Q1
$2.05M Sell
38,896
-8,378
-18% -$418K ﹤0.01% 2582
2017
Q4
$2.2M Sell
47,274
-6,502
-12% -$274K ﹤0.01% 2582
2017
Q3
$2.18M Sell
53,776
-7,158
-12% -$259K ﹤0.01% 2576
2017
Q2
$2.07M Buy
60,934
+6,967
+13% +$215K ﹤0.01% 2560
2017
Q1
$1.57M Sell
53,967
-61,669
-53% -$1.88M ﹤0.01% 2720
2016
Q4
$3.8M Buy
115,636
+89,298
+339% +$2.68M 0.01% 2155
2016
Q3
$830K Buy
26,338
+16,039
+156% +$466K ﹤0.01% 3422
2016
Q2
$290K Sell
10,299
-12,320
-54% -$483K ﹤0.01% 4163
2016
Q1
$821K Buy
22,619
+20,017
+769% +$707K ﹤0.01% 3570
2015
Q4
$104K Sell
2,602
-134
-5% -$4.67K ﹤0.01% 5340
2015
Q3
$78K Sell
2,736
-140
-5% -$4.61K ﹤0.01% 5127
2015
Q2
$95K Sell
2,876
-7,372
-72% -$229K ﹤0.01% 5039
2015
Q1
$295K Buy
10,248
+8,685
+556% +$249K ﹤0.01% 4178
2014
Q4
$42K Sell
1,563
-3,260
-68% -$77.7K ﹤0.01% 5804
2014
Q3
$103K Buy
4,823
+3
+0.1% +$69 ﹤0.01% 4739
2014
Q2
$108K Buy
4,820
+1,513
+46% +$35.2K ﹤0.01% 4609
2014
Q1
$84K Sell
3,307
-6,809
-67% -$172K ﹤0.01% 5138
2013
Q4
$232K Buy
10,116
+5,998
+146% +$125K ﹤0.01% 4523
2013
Q3
$78K Sell
4,118
-5,768
-58% -$103K ﹤0.01% 4921
2013
Q2
$143K Buy
+9,886
New +$143K ﹤0.01% 4550

Other funds holding EBS